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Anorectal complications in patients with
haematological malignancies
Rafaela V. Loureiroa, Verónica P. Borgesa, Ana L. Toméb, Carlos F. Bernardesa, Mário J. Silvaa and
Maria J. Bettencourta
Background Anorectal complications are common in patients with haematological malignancies.
Objectives The objectives are to characterize anorectal complications in these patients, identify risk factors and shed light on
treatment, morbidity and mortality rates.
Patients and methods A retrospective, observational study that included 83 inpatients with haematological malignancies and
proctological symptoms from January 2010 to September 2015 was conducted. Clinical outcomes were obtained through a
detailed review of medical records.
Results The median age was 56 years, and 52 (62.7%) patients were men. Fifty-six (67.5%) patients had nonseptic anorectal
complications and 27 (32.5%) patients had septic anorectal complications.
Risks factors Patients with septic anorectal complications were more commonly male, older, and had lower absolute neutrophil
counts, but the differences were not statistically significant (P=0.79, 0.67 and 0.89, respectively). In positive blood cultures
[23/70 (32.9%)], Enterococcus faecium, Klebsiella pneumonia, and Escherichia coli were the most common isolated agents.
Treatment In nonseptic anorectal complications, conservative treatments/minor proctological procedures were adopted, and
patients with septic anorectal complications were treated with antibiotics ±major proctological procedures and/or surgical
drainage/debridement.
Results of treatment Forty-eight (85.7%) patients in the nonseptic complications group improved compared with 23 (85.2%)
patients in the septic complications group. The overall mortality rate was 2.4% (n=2), with one (1.2%) death related to perianal
sepsis.
Conclusion Enterococcus spp. were more commonly identified in this study and can be increasing in this specific population. In
contrast to other reports, we did not identify an association between septic anorectal complications and possible risk factors
such as male sex, younger age or a low absolute neutrophil count. Most patients had nonseptic anorectal complications. A major
proctological procedure/surgical debridement should always be applied in septic complications, which have better prognoses
now than in the past. Eur J Gastroenterol Hepatol 00:000–000
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Anorectal complications in patients with haematological
malignancies have long been known [1]. Palma [1] showed
a relationship between haematological diseases and an
increase in anorectal complications, with anorectal mani-
festations possibly being the first manifestations of hae-
matological diseases.
Later, Schimpff et al. [2] studied a population of 581
patients and concluded that there is an increase in perianal/
perirectal infections in patients with haematological can-
cers compared with patients with nonhaematological
cancers (6.5 vs. 0.5%).
Moreover, the development of anorectal complications
has been associated with worse prognosis, with a mortality
rate of up to 50% [2–4].
Patients with haematological malignant diseases are
immunocompromised and therefore particularly prone to
anorectal complications. Multiple etiopathogenic factors
have been identified: alterations in mucocutaneous barriers
owing to haematological diseases or previous anorectal
diseases, predisposition for bacterial invasion, some types
of intestinal dysfunction such as diarrhoea or constipation
(which can be related or unrelated to therapy), immuno-
suppression owing to loss of normal leucocyte function or
chemotherapy, granulocytopenia with granulocyte counts
lower than 500 cells/mm3, thrombocytopenia that leads to
delayed healing and opportunistic infections owing to
immunosuppression [2,3,5–8].
The diagnosis of an anorectal complication in such
patients may be challenging, especially when differentiat-
ing between septic or nonseptic complications. A careful
proctologic examination should always be performed and
should be complemented with radiological imaging
(ultrasound or MRI) [8–10].
In the past, incision and drainage in such patients was
controversial, owing to the fear of impaired healing in
Departments of aGastroenterology and bHematology, Central Lisbon Hospital
Center, Lisboa, Portugal
Correspondence to Rafaela V. Loureiro, MD, Santo António dos Capuchos
Hospital - Central Lisbon Hospital Center, Alameda de Santo António dos
Capuchos, 1169-050 Lisboa, Portugal
Tel/fax: + 351 213 136 320; e-mail: loureiro.rafaela@gmail.com
Received 21 October 2017 Accepted 10 March 2018
European Journal of Gastroenterology & Hepatology 2018, 00:000–000
Keywords: haematological malignancy, proctologic disease, risk factors
’Original article
0954-691X Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/MEG.0000000000001133 1
Copyright r 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
immunosuppressed patients, possibly aggravating the local
disease progress. Supportive measures such as stool soft-
eners, antidiarrhoeal agents, sitz baths, warm compresses,
and antibiotics were the recommended treatments [2,3].
Several studies established the benefits of incision and
surgical debridement as the preferable treatments in septic
complications, in conjunction with supportive measures, and
this is currently the recommended therapy [5,8,10–12].
The evolution of local treatments associated with
improvements in the supportive care of patients with
neutropenic cancer resulted in a decrease in infection-
related morbidity and mortality [5,7,11,13].
The objectives of this study are to examine the treatment
of a contemporary series of patients with malignant hae-
matological diseases and anorectal complications, to identify
the risk factors for anorectal complications in a con-
temporary series of these patients, to shed light on the results
of treatment and to shed light on the actual mortality rate.
Patients and methods
Patients
We retrospectively reviewed the medical records of all
patients admitted to the Haematology Department of
Central Lisbon Hospital Center from January 2010 to
September 2015 who had at least one proctological eva-
luation during the admission episode. This included only
adult patients who were 18 years old or older.
All patients who were younger than 18 years or older
than 80 years, had HIV 1 and 2 infections, had inflam-
matory bowel disease, were pregnant, did not have hae-
matological malignancies, had other oncological diseases
or showed incomplete data were excluded. Patients with
proctological diseases diagnosed in the year before the
admission were also excluded.
The study was approved by the ethics committee.
Variables
A detailed review of medical records was performed to
retrieve demographic data and disease-related and
treatment-related details regarding both haematological
and proctological disorders.
Only blood cultures performed in the 3 days before and
3 days after proctological evaluations were considered.
Blood cultures were performed for all patients with fevers
or when their haematologist considered them necessary.
The absolute neutrophil counts at the time of the devel-
opment of the anorectal complications were recorded. A
gastroenterologist expert in proctology performed the
diagnoses of the anorectal complications based on clinical
symptoms and physical examination. When necessary, the
diagnosis was complemented by MRI, endoanal ultra-
sonography and/or examination under anaesthesia.
Anorectal complications were classified into two
groups: nonseptic complications and septic complications.
Nonseptic complications included anal fissures, haemor-
rhoidal diseases (including haemorrhoidal disease grades
II, III and IV and haemorrhoidal trombosis) and anorectal
ulcers. Septic complications included anorectal abscesses,
perianal fistulas [including types 1 (intersphincteric fis-
tula), 2 (trans-sphincteric fistula) and 3 (suprasphincteric
fistula) of Park’s classification] [14] and perianal cellulitis.
Inpatient and outpatient records were evaluated during
a follow-up period of 30 days to assess the course and the
resolution of anorectal complications.
Statistical analysis
Continuous variables were presented as medians and ranges.
Categorical variables were presented as proportions.
Comparisons between nonseptic and septic complica-
tions according to age, sex, absolute neutrophil counts or
positive blood cultures were performed using Fisher’s
exact test or χ2-test as deemed appropriate. A multivariate
logistic regression analysis was performed and a sig-
nificance criterion of P less than or equal to 0.05 was
defined for analysis.
All statistical analyses were performed using Microsoft
Office Excel 2013 (Microsoft Corporation, Redmond,
Washington, USA) and STATA 12.1 (StataCorp LP, College
Station, Texas, USA).
Results
A total of 100 patients were observed at the proctology
department during the allotted time period. Seventeen
patients were excluded: one without a haematological
malignancy, one over the age of 80 years, one with a HIV
1 infection, two with other concomitant oncological dis-
eases, two with proctological diseases diagnosed in the
year before the admission and 10 owing to incomplete
data. None of the patients had inflammatory bowel disease
or were pregnant. Thus, 83 inpatients with haematological
malignant diseases and anorectal complications were
included in the present analysis. Table 1 shows the patient
baseline characteristics and haematological diseases.
Sixty-eight (81.9%) patients had active haematological
diseases, and the rest were in haematological remission
and were admitted due to complications related to treat-
ment. Eighty (96.4%) patients underwent chemotherapy
within the previous 15 days.
Twenty (24.1%) patients had no neutropenia (absolute
neutrophil count ≥ 1500 cells), one (1.2%) patient had
mild neutropenia (absolute neutrophil count 1000–1500
cells), five (6.0%) patients had moderate neutropenia












Acute myeloid leukaemia 54 (65.1)
Chronic myeloid leukaemia 1 (1.2)
Acute lymphoblastic leukaemia/lymphoma 12 (14.5)
Common B cell 4 (4.8)
Pre-B cell 3 (3.6)
T cell 5 (6.0)
Non-Hodgkin’s lymphoma Burkitt 4 (4.8)
Hodgkin’s lymphoma 1 (1.2)
Non-Hodgkin’s lymphoma 11 (13.3)
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(absolute neutrophil count 500–1000 cells) and most
patients [57 (68.7%)] had severe neutropenia (absolute
neutrophil count <500 cells). Of the patients with severe
neutropenia, 54 had fever (T≥ 38.0°C).
Blood cultures were not considered for 14 of the
patients because they were not performed in the 3 days
before and 3 days after the proctological evaluation. Of
the 70 patients for whom blood cultures were obtained at
the time of anorectal symptoms, cultures were negative in
47 (67.1%) patients and positive in 23 (32.9%) patients.
Positive blood culture organisms included: Enterococcus
faecium in six (26.1%) patients, Klebsiella pneumoniae in
six (26.1%) patients, Escherichia coli in five (21.7%)
patients, Enterobacter cloacae in two (8.7%) patients and
Acinetobacter baumannii, Pseudomonas aeruginosa,
Stenotrophomonas maltophila and methicillin-resistant
Staphylococcus epidermidis in one (4.3%) patient each.
The main proctological complaints in patients with non-
septic anorectal complications were proctalgia [43 (76.8%)],
rectal bleeding [32 (57.1%)] and prolapse [18 (32.1%)]; in the
patients with septic anorectal complications, the main proc-
tological complaints were proctalgia [26 (96.3%)], perianal
tumefaction 17 (63.0%)] and discharge [12 (44.4%)].
Diarrhoea was more common in patients with septic anorectal
complications [seven (25.9%) vs. 12 (21.4%)] and constipa-
tion was more common in patients with nonseptic anorectal
complications [12 (21.4%) vs. one (3.7%)].
Most patients [56 (67.5%)] had nonseptic anorectal
complications: anal fissures in 30 (36.1%) patients; hae-
morrhoidal disease grades II, III or IV [including hae-
morrhoidal thrombosis, six (7.2%)] in 22 (26.5%)
patients; and anorectal ulcers in four (4.8%) patients. In
this group, conservative treatments (stool softeners, anti-
diarrhoeal agents, sitz baths, warm compresses, oral or
topic analgesics, venotropics or antibiotics) or minor
proctological procedures (thrombectomy or polidocanol
sclerotherapy) were adopted, with an improvement of
symptoms or a complete resolution in most patients [48
(85.7%)]. At a 30-day follow-up, seven (12.5%) patients
remained symptomatic and one (1.8%) patient died of
another cause (pneumonia).
Twenty-seven (32.5%) patients had septic anorectal
complications: perianal fistulas in 13 (15.7%) patients
(two suprasphincteric fistulas, five trans-sphincteric fistulas
and six intersphincteric fistulas), anorectal abscesses in
nine (10.8%) patients and perianal cellulitis in five (6.0%)
patients. In this group, 12 (44.4%) patients were treated
with antibiotics and the remaining 15 (55.6%) patients
underwent fistula cannulation procedures and seton pla-
cements (and when indicated, fistulotomies) or surgical
drainage/debridement in conjugation with antibiotherapy.
At a 30-day follow-up, there was an improvement of
symptoms or a complete resolution in 23 (85.2%) patients.
Three (11.1%) patients remained symptomatic and one
(3.7%) died owing to perianal sepsis. The patient who died
was a 41-year-old female with P. aeruginosa bacteremia, a
very low neutrophil count (20 cells) and perianal cellulitis.
Figure 1 shows the outline of therapeutic management and
results.
The overall mortality rate was 2.4% (two deaths), with
only one death (1.2%) related to perianal sepsis.
Patients who had septic anorectal complications were
more commonly male, were older and had lower absolute
neutrophil counts, but no differences were statistically
significant in the multivariate logistic regression: male sex
[odds ratio (OR)=1.152, 95% confidence interval (95%
CI)= 0.414–3.208, P= 0.786], younger age (OR=1.266,
95% CI= 0.425–3.769, P= 0.672), low absolute neu-
trophil count (OR=1.082, 95% CI=0.360–3.250,
P=0.889) and positive blood culture (OR= 0.660, 95%
CI=0.227–1.919, P= 0.446) (Table 2).
Discussion
Anorectal complications are more frequent in patients with
haematological malignant diseases compared with patients
with other cancers [1,2]. Early identification of predis-
posing factors, early diagnosis and prompt treatment are
mandatory for reducing morbidity and mortality.
In our study, the major proctological complaints were
very similar in patients with nonseptic and septic anorectal
complications, with proctalgia being the most common
complaint in both groups (83.1%). The differential diag-
nosis based on patients’ histories can be challenging and
should be complemented with careful proctological
examinations and radiological imaging [8–10].
All patients were examined by a gastroenterologist
expert in proctology under mild sedation or, if necessary,
under anaesthesia, and examinations were complemented
with MRI or endoanal ultrasonography when necessary.
None of the patients with nonseptic complications devel-
oped a septic complication during the follow-up period.
Most patients with anorectal complications had active
haematological diseases or underwent chemotherapy
within the previous 15 days, which seem to be risk factors
for anorectal complications; however, these were not sta-
tistically analysed owing to a reduced number of patients
in the ‘haematologic disease in remission’ and ‘no
chemotherapy’ arms.
Previous reports suggest chemotherapy as a risk factor
for anorectal complications [2,7].
E. faecium, K. pneumoniae and E. coli were the most
common bacteria isolated from blood cultures (73.9%),
which was expectable owing to a combination of immuno-
suppression, colonisation of perianal skin by enteric flora and
breaks in anorectal mucosal integrity [6,8]. The positivity for
E. coli is similar to previous reports [2,3,5,8,12,15]; however,
positive blood cultures for P. aeruginosa were more frequent
in other previous studies [2,5,8]. This could be explained
because most patients underwent antibiotherapy with a
spectrum covering P. aeruginosa. In our series, Enterococcus
spp. were more commonly identified than in previous reports
[2,3,5,8,12,15].
Others studies should be done to evaluate if
Enterococcus spp. infections are increasing in this specific
patient population.
Similar to other studies, most patients with haemato-
logical diseases and proctological complaints were diag-
nosed with nonseptic anorectal complications (67.5 vs.
32.5%) such as anal fissures, haemorrhoidal diseases
(including haemorrhoidal thrombosis) and anorectal ulcers
[3,4,10,15].
In the general population, haemorrhoidal diseases are
more common than anal fissures [16,17]; however, in this
series of patients with haematological malignancies, anal
fissures were more frequent than haemorrhoidal diseases
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(including haemorrhoidal thrombosis), 30 (36.1%) vs. 22
(26.5%), which is presumably owing to their haematolo-
gical conditions and immunocompromised statuses.
In this group, conservative treatments or minor proctologic
procedures were adopted, with either an improvement of
symptoms or a complete resolution in most patients (85.7%).
Twenty-seven (32.5%) patients had septic anorectal
complications such as perianal fistulas, anorectal abscesses
and perianal cellulitis, and they were managed with anti-
biotherapy alone or antibiotherapy in conjunction with
fistula cannulation procedures and seton placements (and
when indicated, fistulotomies) or surgical drainage/debride-
ment. Most patients (85.2%) achieved either an improve-
ment or a complete resolution of symptoms.
The only death associated with perianal sepsis occurred
in a patient with perianal cellulitis in whom a surgical
drainage/debridement could not be performed because of
the severe neutropenia.
In our study, and similar to previous reports, early
incision and surgical debridement in cases of patients with
septic complications showed clear benefits and therefore
should always be applied when appropriate [5,8,10–12].
The overall mortality rate was 2.4%, with only one
(1.2%) death related to perianal sepsis, which was very
similar to recent studies and much lower than it was in the
past. The improvement in outcomes in recent studies might
be attributed not only to adequate management of anorectal
complications but also to an improvement in the supportive
care of patients with neutropenic cancer [5,7,11,13].
In contrast to other studies, we did not identify an
association between septic anorectal complications and
possible independent risk factors such as male sex, a
younger age, a low absolute neutrophil count or a positive
blood culture. A relationship between septic anorectal
complications and a younger age was only established in
one study [10], but other studies showed a consistent
association between a lower absolute neutrophil count and
male sex and an increased incidence of septic anorectal
complications in patients with haematological diseases
[2,4,8–10]. The inability to demonstrate such associations
may be owing to the small patient population.
All patients were examined in a single proctology
department where the practices between different expert
proctologists are very similar, which is a strong point of
the study. However, this study has some potential limita-
tions, as it is a single-centre study, has a retrospective study
design and has a small study population.
As explained above, future studies aiming to identify
the microorganisms implied in these conditions and other
possible risk factors may have a significant effect in the
identification of at-risk patients, thus improving manage-
ment of these patients and preventing this condition.
This study demonstrates that nonseptic anorectal com-
plications can be managed with conservative treatment;
however, surgical debridement or proctologic procedures
should often be applied in cases of septic complications,
which have better prognoses now than in the past.
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Fig. 1. Therapeutic management and results.
Table 2. Multivariate logistic regression analysis – risk factors for septic
anorectal complications
Risk factors Odds ratio 95% confidence interval P value
Age (<40 years) 1.266 0.425–3.769 0.672
Sex (male) 1.152 0.414–3.208 0.786
ANC (<500 cells) 1.082 0.360–3.250 0.889
Blood culture (positive) 0.660 0.227–1.919 0.446
ANC, absolute neutrophil count.
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